BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The European School of Multimodality Imaging &amp; Therapy (ESMIT) - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The European School of Multimodality Imaging &amp; Therapy (ESMIT)
X-ORIGINAL-URL:https://esmit.eanm.org
X-WR-CALDESC:Events for The European School of Multimodality Imaging &amp; Therapy (ESMIT)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250410T090000
DTEND;TZID=Europe/Vienna:20250411T160000
DTSTAMP:20260523T075231
CREATED:20241017T083229Z
LAST-MODIFIED:20250318T094444Z
UID:1955-1744275600-1744387200@esmit.eanm.org
SUMMARY:Treatment of Metastatic Bone Pain Using Bone-Seeking Agents
DESCRIPTION:Internal radiotherapy with bone-seeking agents is effective in delivering high doses of radiation to widespread metastatic bone lesions and may limit the radiation absorbed dose to healthy tissue. Beta emitter have long been preferred agents for bone pain palliation. The approval of 223Ra and data showing a prolonged survival with alpha emitter are favored in bone pain palliation. Unfortunately\, we do not have good data on the survival after treatment with beta emitters. In the face-to-face course we will discuss the pathophysiology of bone pain to understand the principle of therapeutic effect of bone seeking agents. Dosimetry is essential to increase the dose to the tumor by limiting of severe side effects. All the focus is on the alpha emitters only\, based on the poor data about survival data for the beta emitters. The future of therapy in Nuclear Medicine is the combination with other agents to improve the therapeutic effect\, e.g. chemotherapy\, immunotherapy or anti-androgen therapy. \n\n\n\n\n\n\n\nRegister nowClick on the button to sign up for the course. Register now\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\nPathophysiology and medical treatment of bone pain\n\n\n\nPro/con alpha/beta emitters\n\n\n\nPerforming of dosimetry\n\n\n\nCombination treatment to improve the therapeutic effect\n\n\n\n\n\n\nTarget Audience\n\n\n\n\nNuclear medicine physician\, junior or senior\, with an interest in treatment\n\n\n\n\n\n\n\n\n\nProgrammeView the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\nKnut LiepeSpeakerFrankfurt (Oder)\, Germany \n\n\n\n\nTatiana LouroSpeakerLisbon\, Portugal \n\n\n\n\n\nGiulia SantoSpeakerCatanzaro\, Italy \n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee & Lunch Breaks\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation.
URL:https://esmit.eanm.org/event/treatment-of-metastatic-bone-pain-using-bone-seeking-agents/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Onsite Course,Theranostics
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20250328T133000
DTEND;TZID=Europe/Vienna:20250328T143000
DTSTAMP:20260523T075231
CREATED:20241017T080209Z
LAST-MODIFIED:20250312T095042Z
UID:1926-1743168600-1743172200@esmit.eanm.org
SUMMARY:Theranostic Training: Practical and Methodological Concepts
DESCRIPTION:This webinar aims to introduce the concept of theranostics and provide an overview of its potential. Participants will gain an understanding of how our technological competencies contribute to and enhance theranostic processes\, and how we can leverage these strengths in practice. \n\n\n\nPlease note that the webinar will be recorded\, and the recording will be available a few days after the session is over. You can find the recording on the ESMIT E-learning platform\, under the webinar title. A handout of the presentation materials will also be available on the platform. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnroll in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nAttendees will understand the concept of theranostics and its significance in modern healthcare.\n\n\n\nAttendees will explore the foundational technologies behind theranostics and learn how departments can be organized to integrate theranostic procedures.\n\n\n\nAttendees will gain insights into the perspectives of physicians and technologists on theranostics and how these disciplines collaborate to deliver optimal patient outcomes.\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nTechnologists\, Nurses\, Physicists\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nRiccardo LaudicellaSpeaker \n\n\n\n\n\nDaniela FonsecaSpeaker \n\n\n\n\n\nAngelo CardosoModerator \n\n\n\n\n\nConrad-Amadeus VoltinModerator \n\n\n\n\n\n\n\n\n\n \n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/theranostic-training-for-technologists/
CATEGORIES:Live Webinars,Theranostics
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20241122T133000
DTEND;TZID=Europe/Vienna:20241122T143000
DTSTAMP:20260523T075231
CREATED:20240213T192901Z
LAST-MODIFIED:20241004T123239Z
UID:1298-1732282200-1732285800@esmit.eanm.org
SUMMARY:Challenges of Zr89 Imaging
DESCRIPTION:While PET imaging with radionuclides such as F18 and Ga68 have proven to provide high quality diagnostic imaging\, imaging with other radionuclides can be more challenging. Zr-89 is one such radionuclide. Although Zr-89 has advantageous labelling properties for cell imaging and the imaging of monoclonal antibodies\, the radionuclide is non-ideal imaging qualities mostly due to its low dosage\, and also brings with it radiation safety challenges. This webinar will present both sides of Zr-89 imaging\, the clinically relevant opportunities for the radionuclide\, and the quantification challenges\, handling and the safety aspects of Zr-89. \n\n\n\nLearning Objectives: The aim of this webinar is to show the potential and the challenges of Zr-89 imaging. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nFloris H.P. van VeldenModeratorLeiden\, Netherlands \n\n\n\n\n\nErik AarntzenSpeakerNijmegen\, Netherlands \n\n\n\n\n\nMarc C. HuismanSpeakerAmsterdam\, Netherlands \n\n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/challenges-of-zr89-imaging/
CATEGORIES:Live Webinars,Theranostics
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240516T090000
DTEND;TZID=Europe/Vienna:20240517T170000
DTSTAMP:20260523T075231
CREATED:20240213T181112Z
LAST-MODIFIED:20240422T130229Z
UID:1232-1715850000-1715965200@esmit.eanm.org
SUMMARY:Prostate Cancer Theranostics
DESCRIPTION:UEMS EACCME has granted the accreditation of 8.5 CME credits for this event. \n\n\n\nRadiolabelled prostate-specific membrane antigen (PSMA) is increasingly used for the diagnosis (i.e.\, staging and restaging) and treatment of patients with prostate cancer. Radionuclide PSMA therapy is a useful new treatment option in patients with metastatic castration-resistant prostate cancer (mCRPC) and potentially also in patients with hormone-sensitive prostate cancer. The course will cover the spectrum of radiolabelled PSMA tracers and techniques related to PSMA imaging\, from diagnosis to therapy\, with lectures\, interactive case discussions\, and relevant information for clinical practice. \n\n\n\n\n\n\n\n\nThe course is sold out\nPlease contact esmit@eanm.org to get on the wait list. \n\n\n\n\n\n\n\n\n\nTarget Audience\n\n\n\n\nGeneral nuclear medicine specialists\, residents\, radiologists and healthcare specialists who want to update their knowledge on molecular imaging of prostate cancer and radiolabelled PSMA therapy (theranostics).\n\n\n\n\n\n\n\n\nLearning Objectives\n\n\n\n\nPSMA PET-CT imaging- science and practice\n\nTo provide an overview of clinical applications\, normal biodistribution\, variants\, pitfalls and artefacts in PSMA PET-CT\n\n\n\nTo learn how to report PSMA PET-CT scans in a structured manner\n\n\n\n\n\nRadionuclide PSMA therapy-science and practice (177Lu-PSMA and 225Ac-PSMA therapies)\n\nTo gain knowledge on PSMA-based patients selection when planning radionuclide therapies\n\n\n\nTo become familiar with common clinical challenges and side effects  management\, when implementing and delivering radionuclide therapies\n\n\n\nTo discuss current evidence and trends related to 177Lu-PSMA and 225Ac-PSMA therapies\n\n\n\nTo learn about new or emerging targets and radioisotopes for Prostate cancer management.\n\n\n\n\n\n\n\n\n\n\nProgrammeClick to see the Preliminary Programme. Please note\, that it may be subject to change at any time. View the Programme\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nDaniela Oprea – LagerSpeakerAmsterdam UMC The Netherlands \n\n\n\n\n\nKarolien GoffinSpeakerUZ Leuven Belgium \n\n\n\n\n\nWolfgang FendlerSpeakerUK EssenGermany \n\n\n\n\n\n\n\n\n\nRegistration Details\n\n\n\nRegistration FeeMode of PaymentCancellation Policy\n\nCourse Fee               € 950.- \n\n\n\nRegistration Fee includes: \n\n\n\n\nElectronic Course Book\, including all Slides\n\n\n\nCoffee breaks on each Course Day\n\n\n\nLunch on Day 1\n\n\n\n\nRegistration Fee does NOT include: \n\n\n\n\nTravel to the Venue\n\n\n\nAccommodation\n\n\n\n\n\n\nRegistration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline\, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted \n\n\n\n\n\nCancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course\, we will refund you the fee less a € 100\,- administration charge. After this date\, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels\, airlines or other means of transportation. \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/prostate-cancer-theranostics/
LOCATION:Future Health Lab\, Alfred-Adler-Straße 1\, Vienna\, 1100\, Austria
CATEGORIES:Onsite Course,Theranostics
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20240419T133000
DTEND;TZID=Europe/Vienna:20240419T143000
DTSTAMP:20260523T075231
CREATED:20240213T185845Z
LAST-MODIFIED:20240409T141814Z
UID:1280-1713533400-1713537000@esmit.eanm.org
SUMMARY:Exploiting Radiobiological Effects of Targeted Radionuclide Therapy
DESCRIPTION:Radiobiology is a branch of biology devoted to the study of biological effects of ionizing radiation on living organisms: we can speak about radiobiology in different clinical and research settings of Nuclear Medicine: dosimetry\, preclinical and translational science\, oncology\, theranostics. With this webinar we will try to better understand the importance of this topic regarding targeted radionuclide therapy\, in particular we will start from the questions from a clinician’s side with a great experience in PRRT and we will move towards the possible answers from experts in dosimetry and radiobiology.  \n\n\n\nRadiobiology is fundamental to better understand some mechanisms of response to therapies and also in order to reach the most important target: we always need more efficient and safer radiopharmaceuticals for personalized cancer diagnosis and treatment. \n\n\n\nLearning Objectives: The aim of this course is to understand the importance of radiobiology in radionuclide therapy. \n\n\n\n\n\n\n\nSave yourself a FREE seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now FOR FREE!\n\n\n\n\n\n\n\nFaculty\n\n\n\n\n\nChiara Maria GranaModeratorMilan\, Italy \n\n\n\n\n\nLisa BodeiSpeakerNew York\, USA \n\n\n\n\n\n\nCaroline StokkeSpeakerOslo\, Norway \n\n\n\nJean-Pierre PougetSpeakerMontpellier\, France \n\n\n\n\n\n\n\n\nRegistration\n\n\n\n\nmyEANM accountLog into your myEANM account or create a new one. \n\n\n\nESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations \n\n\n\neLearning Course StoreEnter the course store\, make your selection and check out. \n\n\n\nEnroll yourselfFind your desired webinar under ‘Single Webinar Tickets’ or enroll for all 2024 webinars with the eLearning Access Plan – FREE OF CHARGE \n\n\n\nEnjoy!The link for the Zoom Webinar will be made available to you on the eLearning platform in the course contents \n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/exploiting-radiobiological-effects-of-targeted-radionuclide-therapy/
CATEGORIES:Live Webinars,Theranostics
END:VEVENT
END:VCALENDAR